The IPOX® Week, March 2, 2020

  • IPOX Indexes turn mixed during February, but outperform YTD as COVID-19 fears drive big selling wave in global equities.
  • IPOX China (CNI) adds +5.63% during last month.
  • IPO Deal-flow Review & Outlook: February concludes with solid deal flow and robust initial showing. GFL Environmental on track for its $1.5 billion IPO relaunch.

IPOX Indexes turn mixed February, but outperform YTD as COVID-19 fears drive big selling wave in global equities. IPOX China (CNI) the place to be as index adds +5.63% during February. Most IPOX Indexes lost ground during February, however, outperformed, as increasing fears over the impact of COVID-19 on economic growth drove massive selling in the derivates- and ETF-heavy global equity benchmarks towards month-end, while yields continued to plunge and equity risk spiked. On the global level, for example, the super-liquid, large-cap centric, diversified  IPOX Global (IPGL50) declined by -3.10% to -0.87% YTD last month, extending the relative lead vs. the global market to a large +831 bps. YTD. Big relative strength extended to the IPOX Indexes trading across other markets and regions, such as the IPOX International (ETF: FPXI, +961 bps.), IPOX 100 U.S. (ETF: FPX, +382 bps.) and IPOX 100 Europe (ETF: FPXE, +568 bps.). Notable was also the strong showing of the IPOX

IPOX® 100 U.S. ETF (ticker: FPX) Investing since 04/2006:

China Core (CNI), which gained by +5.63% to +3.09% YTD last month, also significantly ahead of the local market. Here, big gains in little weighed small- and mid-caps centered around a core large-cap position drove the confoundingly strong showing, including medical devices maker AK Medical (1789 HK: +44.70% last month), property manager A-Living Services (3319 HK: +33.97%) and glass products maker Flat Glass (6865 HK: +33.87%). Amid the overall declines last month, notable upside recorded across other regions included online pet food retailer Chewy (CHWY US: +11.66%), electronic signature solutions provider Docusign (DOCU US: +9.94), HK-traded biotech Wuxi Biologics (2269 HK: +14.63%), photovoltaic technologies provider Solaredge (SEDG US: +27.45%), French lottery services provder FDJ (FDJ FP: +16.53%) and Sweden’s private equity firm EQT (EQT SS: +14.60%). Big monthly losses in online car seller Cargurus (CARG US: -28.50%), social media firm Snap (SNAP US: -22.91%), luxury car maker Aston Martin  (AML LN: -32.24%),  Brazil airline Azul (AZUL US: -28.92%) and 97% of all holdings in the IPOX Japan (IPJP: -11.36%), including Japan-traded revolving sushi restaurant chain operator Sushiro Global (3563 JP: -28.92%), weighed.

Select IPOX® Indexes Price Returns (%) Last Week 2019 2020 YTD
IPOX® Indexes: Global/International
IPOX® Global (IPGL50) (USD) -3.10 27.93 -0.87
IPOX® International (IPXI)* (USD) -1.79 31.37 -1.26
IPOX® Indexes: United States
IPOX® 100 U.S. (IPXO)* (USD) -6.54 29.60 -4.74
IPOX® Indexes: Europe/Nordic
IPOX® 30 Europe (IXTE) (EUR) -3.27 34.55 -0.66
IPOX® Nordic (IPND) -1.46 38.52 1.46
IPOX® 100 Europe (IPOE)* (USD) -6.17 30.97 -6.33
IPOX® Indexes: Asia-Pacific/China
IPOX® Asia-Pacific (IPTA) (USD) -5.48 4.41 -5.67
IPOX® China (CNI) (USD) 5.63 26.31 3.09
IPOX® Japan (IPJP)** (JPY) -11.36 37.91 -13.16

* Basis for ETFs: FPX US, FPX LN, FPXE US, FPXU FP, FPXI US, TCIP110 IT and CME-traded e-mini IPOX® 100 U.S. Futures (IPOH0). Source: Bloomberg L.P.

IPOX ETFs 2020 YTD Returns: IPOX 100 U.S. (ETF: FPX): -4.63%; IPOX International (ETF: FPXI): -1.57%; IPOX 100 Europe (ETF: FPXE): -4.86%.

IPO Deal-flow Review and Outlook: February concludes with solid deal flow and robust initial showing. GFL Environmental on track for its $1.5 billion IPO relaunch. 3 firms commenced trading across the global regions last week with the average equally-weighted deal adding +20.73% based on the difference between the final offering price and Friday’s close. Airtel Africa’s spin-off Airtel Malawi (AIRTEL MW: +38.85%) broke the decade-long listing drought with the biggest ever IPO in Malawi, while PE-backed eyewear frame maker Inspecs (SPEC LN: 0.00%) closed flat and genetic therapy startup Passage Bio (PASG US: +23.33%) soared despite the U.S. market sell-off. The IPO pipeline remains steady during the first week of March with Canadian waste management firm GFL (GFL US), French games developer Bigben’s gaming business spin-off NACON (NACON FP), and British restructuring and insolvency specialist FRP Advisory (FRP LN) scheduled to debut. Other IPO News include: 1) German chemical giant BASF is set to continue with plans to IPO it’s oil & gas unit Wintershall’s during 2H IPO; 2) Lithuania prepares IPO of state-owned energy group Ignitis; 3) flash memory maker Kioxia (formerly Toshiba Memory) plans for $32 billion IPO in Japan by October;  4) SoftBank-backed food delivery firm DoorDash, Carlyle-backed B2B contact database ZoomInfo, Chinese bubble tea chain Naixue and African telecom group IHS Towers seek U.S. listing; and 5) K-pop group BTS’s label Big Hit Entertainment progresses toward IPO.
**Terms applies

Track Priced & Upcoming IPOs on https://ipox.com/ipox-deals/

Lime Brokerage LLC is not affiliated with these service providers. Data, information, and material (“content”) is provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lime Brokerage LLC does not endorse, offer or recommend any of the services nor information provided by any of the above service providers and any service or information used to execute any trading strategies are solely based on the independent analysis of the user.

You may also be interested in...

Why European Investors Interested In US ETFs Are Turning To US Brokers
Read More
The IPOX® Week, August 3rd, 2020
Read More
The Tech Trade Cools Off With Earnings On Deck
Read More
The IPOX® Week, July 27, 2020
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.

OK